B O O K - American College of Rheumatology
B O O K - American College of Rheumatology
B O O K - American College of Rheumatology
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
TABLE OF CONTENTS<br />
Systemic Sclerosis, Fibrosing Syndromes and Raynaud’s-Pathogenesis and<br />
Animal Models I<br />
(Abstracts #600 - 619) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 189<br />
ACR/ARHP POSTER SESSION B<br />
(ABSTRACTS #733-1345) . . . . . . . . . . . . . . . . . . . . . . .191<br />
B-Cell Biology and Targets in Autoimmune Disease<br />
(Abstracts #733 - 753) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 191<br />
Epidemiology and Health Services Research: MSK, CTD and SLE<br />
(Abstracts #754 - 796) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 192<br />
Fibromyalgia and S<strong>of</strong>t Tissue Disorders II<br />
(Abstracts #797 - 821) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 195<br />
Genetics, Genomics and Proteomics in the Rheumatic Diseases<br />
(Abstracts #822 - 843) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 196<br />
Innate Immunity and Rheumatic Disease<br />
(Abstracts #844- 868) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 198<br />
Metabolic and Crystal Arthropathies - Pathogenesis, Epidemiology, and<br />
Clinical Manifestations II<br />
(Abstracts #869 - 889) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 200<br />
Miscellaneous Rheumatic and Inflammatory Diseases I<br />
(Abstracts #890- 912) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 201<br />
Muscle Biology, Myositis and Myopathies: New Developments in the<br />
Diagnosis, Pathogenesis and Treatment <strong>of</strong> Myositis<br />
(Abstracts #913- 935) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 203<br />
Osteoarthritis - Clinical Aspects: Pain and Treatment II<br />
(Abstracts #936 - 955) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 205<br />
Osteoporosis and Metabolic Bone Disease: Clinical Aspects and<br />
Pathogenesis<br />
(Abstracts #956 - 983) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 206<br />
Quality Measures and Innovation in Practice Management and Care<br />
Delivery<br />
(Abstracts #984 - 1014) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 208<br />
Rheumatoid Arthritis - Clinical Aspects: Clinical Features, Disease Risk<br />
Factors, Bone in RA, CVD II<br />
(Abstracts #1015 - 1068) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 209<br />
Rheumatoid Arthritis - Human Etiology and Pathogenesis II<br />
(Abstracts #1069 - 1094) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 213<br />
Rheumatoid Arthritis Treatment - Small Molecules, Biologics and Gene<br />
Therapy: Predicting and Measuring Outcomes, Novel Compounds II<br />
(Abstracts #1095 - 1138) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 215<br />
Systemic Lupus Erythematosus - Clinical Aspects and Treatment II<br />
(Abstracts #1139 - 1180) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 219<br />
Systemic Lupus Erythematosus - Human Etiology and Pathogenesis:<br />
Cardiovascular Disease and Clinical<br />
(Abstracts #1181- 1200) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 221<br />
Systemic Sclerosis, Fibrosing Syndromes, and Raynaud’s - Clinical Aspects<br />
and Therapeutics II<br />
(Abstracts #1201- 1239) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 223<br />
T-Cell Biology and Targets in Autoimmune Disease<br />
(Abstracts #1240 - 1274) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 225<br />
Large-Vessel Vasculitis and Behçet’s Disease I<br />
(Abstracts #1275 - 1315) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 227<br />
ARHP Poster Session B: Osteoporosis<br />
(Abstracts #1316 - 1319) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 230<br />
ARHP Poster Session B: Behavioral Science<br />
(Abstracts #1320 - 1326) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 230<br />
ARHP Poster Session B: Foot<br />
(Abstracts #1327 - 1331) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 231<br />
ARHP Poster Session B: Patient Education/Support<br />
(Abstracts #1332 - 1338) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 231<br />
ARHP Poster Session B: Pediatrics<br />
(Abstracts #1339- 1345) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 232<br />
ACR/ARHP POSTER SESSION C<br />
(ABSTRACTS #1466-2079) . . . . . . . . . . . . . . . . . . . . . .233<br />
Biology and Pathology <strong>of</strong> Bone and Joint: Osteoarthritis-Cartilage<br />
Degradation and Skeletal Turnover<br />
(Abstracts #1466 - 1503) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 233<br />
Cell-Cell Adhesion, Cell Trafficking and Angiogenesis<br />
(Abstracts #1504- 1509) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 235<br />
Cytokines, Mediators, Gene Regulation II<br />
(Abstracts #1510 - 1536) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 236<br />
Epidemiology and Health Services Research: OP/OA<br />
(Abstracts #1537 - 1576) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 237<br />
Genetics, Genomics and Proteomics: Rheumatoid Arthritis and SLE<br />
(Abstracts #1577 - 1612) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 240<br />
Imaging <strong>of</strong> Rheumatic Disease II: Ultrasound, PET, Capillary Microscopy<br />
and Molecular Imaging<br />
(Abstracts #1613 - 1637) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 244<br />
Infection-Related Rheumatic Disease<br />
(Abstracts #1638 - 1649) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 246<br />
Miscellaneous Rheumatic and Inflammatory Diseases II<br />
(Abstracts #1650- 1671) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 247<br />
Pediatric <strong>Rheumatology</strong> - Clinical and Therapeutic Aspects: Pediatric<br />
Rheumatic Diseases II<br />
(Abstracts #1672 - 1706) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 248<br />
Rheumatoid Arthritis - Animal Models: Pathogenesis, Novel Targets and<br />
Technology<br />
(Abstracts #1707 - 1733) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 252<br />
Rheumatoid Arthritis - Clinical Aspects: Classification, Biomarkers,<br />
Predictors <strong>of</strong> Response, Disease Activity, Severity III<br />
(Abstracts #1734 -1787) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 254<br />
Rheumatoid Arthritis Treatment - Small Molecules, Biologics and Gene<br />
Therapy: Biologic DMARDs III<br />
(Abstracts #1788 - 1841) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 257<br />
Systemic Lupus Erythematosus - Clinical Aspects and Treatment-<br />
Epidemiology and Health Services III<br />
(Abstracts #1842 - 1882) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 262<br />
Sjögren’s Syndrome<br />
(Abstracts #1883- 1918) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 265<br />
Spondylarthropathies and Psoriatic Arthritis - Clinical Aspects and<br />
Treatment II<br />
(Abstracts #1919 - 1964) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 268<br />
Spondylarthritis and Psoriatic Arthritis - Pathogenesis, Etiology, and<br />
Animal Models<br />
(Abstracts #1965- 1986) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 271<br />
6<br />
2010 Program Book